Thyrotropin levels and their relationship with cardiovascular risk factors in the island of Gran Canaria, Spain. Implications of lowering the upper reference limit of thyrotropin stimulating hormone

Journal of Endocrinological Investigation

Volumn 32, Issue 2, 2009, Pages 102-106

  Alberiche, M ^a,e   Boronat, M ^a   Saavedra, P ^b   Perez N ^a   Marrero, D ^a   Lopez Plasencia Y ^a   Varillas, V F ^c   Rios M ^d   Novoa F J ^a  

^a Bone Metabolic Unit Hospital University Insular   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c Service of Internal Medicine   (Spain)

^d University Hospital Complex of Vigo   (Spain)

^e HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Cardiovascular risk factors; TSH

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; INSULIN; LEVOTHYROXINE; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR; THYROTROPIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HORMONAL REGULATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; SMOKING; THYROTROPIN BLOOD LEVEL;

EID: 67649344675     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345695     Document Type: Article

References (40)

1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160: 526-34.
2. Hollowell J, Staehling N, Flanders D, et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87: 489-99.
3. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk and mortality in older adults. JAMA 2006, 295: 1033-41.
4. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005, 165: 2460-6.
5. Walsh JP, Bremmer AP, Bulsara MK, et al. Subclinical thyroid dysfunction ass risk for cardiovascular disease. Arch Intern Med 2005, 165: 2467-72.
6. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228-38.
7. Waterhouse DF, McLaughlin AM, Walsh CD, Sheehan F, O'Shea D. An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: A study in healthy women. Thyroid 2007, 17: 243-8.
8. Roos A, Bakker 5, Links T, Gans R, Woiffenbuttel B. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007, 92: 491-6.
9. Boronat M, Varillas VF, Saavedra P, et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): Prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med 2006, 23: 148-55.
10. Nóvoa FJ, Boronat M, Saavedra P et al. Differences in cardiovascular risk factors, insulin resistance and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation. Diabetes Care 2005, 28: 2388-93.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in roan. Diabetologia 1985, 28: 412-9.
12. Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD. Two simple methods for measuring iodine in urine. Thyroid 1993, 3: 119-23.
13. Baloch Z, Carayon P, Conte-Devolx B, eta1; Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13: 3-126.
14. World Health Organization Department of Non Communicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. 1999 Geneva, World Health Organisation, WHO/NCD/NCS/99.2).
15. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109: 433-8.
16. Diez JJ, Molina I, Ibars MT. Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp Clin Endocrinol Diabetes 2003, 11: 480-5.
17. Sender Palacios MJ, Vernet Vernet M, Pérez López s, Faro Colomés M, Rojas Blanc M, Pallisa Gabriel L. Functional thyroid pathology in the elderly. Aten Primaria 2004, 34: 192-7.
18. Ania Lafuente BJ, SuárezAlmenara JL, Fernández-Burriel Tercero M, Gueraa Hemández L, Betancort Mastrángelo C. Thyroid function in the aged admitted to a nursing home. An Med Interna 2000, 17: 5-8.
19. Betancor E, Aguado R, Gómez-Carracedo A, Baztán JJ. Prevalence of thyroid dysfunction in hospitalized older persons. Med Clin (Barc) 2004, 123: 77-8.
20. Hoogendoorn EH, Hermus AR, de Vegt F, et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: Influences of age and sex. Clin Chem 2006, 52: 104-11.
21. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and anthtyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007, 92: 4575-82.
22. Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associat ed with BMI. Int J Obesity (Lond) 2006, 30: 100-5.
23. Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005, 90: 401 9-24.
24. Asvold BO, Vatten U, Nilsen TIL, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. EurJ Endocrinol 2007, 156: 181-6.
25. Michalopoulou G, Alevizaki M, Piperingos G, et al. High serum cholesterol levels in persons with 'high-normal' TSH levels: Should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998, 138: 141-5.
26. Tunbridge WM, Evered DC, Hall R, at al. Lipid profiles and car diovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 1977, 7: 495-508.
27. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2004,2:351-5.
28. Walsh JP, BremnerAP, Bulsara MK, et al. Thyroid dysfunction and serum lipids: A community-based study. Clin Endocrinol (Ox 2005, 63: 670-5.
29. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 2001, 155: 195-200.
30. Lindeman RD, Romero Li, Schade DS, Wayne S, Baumgartner RN, Gerry PJ. Impact of subclinical hypothyroidism on serum total ho mocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Thyroid 2003. 13: 595-600
31. Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardio vascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf) 2005, 63: 582-7.
32. Cantürk Z, Cetinarsian B, Tarkun I, Cantürk NZ, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2003, 13: 971-7.
33. Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibod ies and thyrotropin concentration elevation and a higher preva lence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2004, 89: 6077-86.
34. Asvold BO, Bjøro T, Nilsen TIL, Vatten LJ. Tobacco smoking and thyroid function: A population-based study. Arch Intern Med 2007, 167: 1428-32.
35. Saito I, Ito K, Saruta T. Hypothyroidism ass cause of hypertension. Hypertension 1983, 5: 112-5.
36. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dys function and blood pressure: A community-based study. Clin Endocrinol (Oxf) 2006, 65: 486-91.
37. Iqbal A, Figenschan Y, Jorde R. Blood pressure in relation to serum thyrotropin: The Tromsø Study. J Hum Hypertens 2006, 20: 932-6.
38. Asvold BO, Bjoro T, Nilaen TJ, Vatten U. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: A population-based study. J Clin Endocrinol Metab 2007, 92: 841-5.
39. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002, 12: 421-5.
40. Nagasaki T, Inaba M, Kumeda Y, et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 2006, 91: 154-8.